Topical Liposomal Ozonated Oil in Complicated Corneal Disease: A Report on Three Clinical Cases

Fedele Passidomo, Francesco Pignatelli, Giuseppe Addabbo, Ciro Costagliola, Fedele Passidomo, Francesco Pignatelli, Giuseppe Addabbo, Ciro Costagliola

Abstract

Infectious and traumatic corneal diseases require adequate therapy against infection and promote re-epithelialization. The appearance of multidrug-resistant bacterial strains, induced by excessive use of antibiotics in the treatment of infectious diseases, has urged researchers to study new antimicrobial formulations. Ozonated oils have demonstrated antiseptic (antibacterial, antifungal and antiviral) and reparative properties and can be proposed for the prevention and treatment of acute and chronic local infections, as an alternative to conventional topical antimicrobials. In ocular treatment, ozonated oil can exert tissue repair and anti-inflammatory and bactericidal activity. Moreover, its specific formulation makes it well tolerated and biocompatible with the ocular surface. Herein, we report on three cases of corneal inflammation (dendritic epithelial keratitis, corneal injuries caused by olive leaves, and neurotrophic corneal ulcer), treated with liposomal ozonated oil (Ozodrop®, FB VISION S.p.a. San Benedetto del Tronto, Italy), successfully resolved using topical liposomal ozonated oil.

Keywords: corneal trauma; corneal ulcers; corneal wound healing; infectious keratitis; ozonated oil.

Conflict of interest statement

The authors report no conflicts of interest in this work.

© 2021 Passidomo et al.

Figures

Figure 1
Figure 1
Right eye of a 56-year-old patient with dendritic epithelial keratitis during the follow-up period ((A): baseline; (B): after 3 days; (C): after 4 days; (D): after 7 days).
Figure 2
Figure 2
A 65-year-old man immediately after a corneal trauma caused by an olive leaf ((A): Large inferior trauma between 2 and 6 o’clock; (B): after 2 days; (C): after 3 days of treatment).
Figure 3
Figure 3
Corneal abscess in a 63-year-old woman ((A): slit lamp; (B): corneal OCT; (C): after 3 days; (D): after 5 days; (E): corneal confocal microscopy after 5 days; (F): corneal abscess nearly solved after 7 days; (G): after 10 days; (H): after 12 days; (IK): the OCT examination shows a gradual and progressive normalisation of corneal anatomy, with resolution of the abscess area and the ulcer).

References

    1. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. PT. 2015;40:277–283.
    1. Ting DSJ, Ho CS, Cairns J, et al. 12-year analysis of incidence, microbiological profiles and in vitro antimicrobial susceptibility of infectious keratitis: the Nottingham Infectious Keratitis Study. Br J Ophthalmol. 2020.
    1. Smith NL, Wilson AL, Gandhi J, Vatsia S, Khan SA. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res. 2017;7(3):212–219. doi:10.4103/2045-9912.215752
    1. Celenza G, Iorio R, Cracchiolo S, et al. Antimycotic activity of ozonized oil in liposome eye drops against Candida spp. Transl Vis Sci Technol. 2020;9:4. doi:10.1167/tvst.9.8.4
    1. Spadea L, Tonti E, Spaterna A, Marchegiani A. Use of ozone-based eye drops: a series of cases in veterinary and human spontaneous ocular pathologies. Case Rep Ophthalmol. 2018;9:287–298. doi:10.1159/000488846
    1. Cagini C, Mariniello M, Messina M, et al. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial. Int Ophthalmol. 2020;40:3209–3215. doi:10.1007/s10792-020-01503-4
    1. Mohamed MSM, Abdallah AA, Mahran MH, Shalaby AM. Potential alternative treatment of ocular bacterial infections by oil derived from Syzygium aromaticum flower (clove). Curr Eye Res. 2018;43:873–881. doi:10.1080/02713683.2018.1461907
    1. Kim HS, Noh SU, Han YW, et al. Therapeutic effects of topical application of ozone on acute cutaneous wound healing. J Korean Med Sci. 2009;24:368–374. doi:10.3346/jkms.2009.24.3.368
    1. Farooq AV, Shukla D. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol. 2012;57(5):448–462. doi:10.1016/j.survophthal.2012.01.005
    1. Sibley D, Larkin DFP. Update on Herpes simplex keratitis management. Eye (Lond). 2020;34:2219–2226. doi:10.1038/s41433-020-01153-x
    1. Raizman MB, Hamrah P, Holland EJ, et al. Drug-induced corneal epithelial changes. Surv Ophthalmol. 2017;62:286–301. doi:10.1016/j.survophthal.2016.11.008
    1. White ML, Chodosh J. Herpes simplex virus keratitis: a treatment guidelines. Am Acad Ophthalmol. 2014.
    1. Willmann D, Fu L, Melanson SW. Corneal injury. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
    1. Silva V, Peirone C, Amaral JS, et al. High efficacy of ozonated oils on the removal of biofilms produced by methicillin-resistant Staphylococcus aureus (MRSA) from infected diabetic foot ulcers. Molecules. 2020;25(16):3601. doi:10.3390/molecules25163601
    1. Versura P, Giannaccare G, Pellegrini M, Sebastiani S, Campos EC. Neurotrophic keratitis: current challenges and future prospects. Eye Brain. 2018;10:37–45. doi:10.2147/EB.S117261

Source: PubMed

3
Abonner